Annabidiol(ACBD)
$0.440.00 (0.00%)
ACBD
Annabidiol financials statements
$0.44
At close:0.00 (0.00%)
Annabidiol (ACBD) Ratios
12 Followers
Annabidiol Ratios
ACBD's free cash flow for Q2 2024 was $-7.01K. For the 2024 fiscal year, ACBD's free cash flow was increased by $0.00 and operating cash flow was $-7.01K. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 0.05 | 0.00 | 0.10 |
| Quick Ratio | 0.05 | 0.00 | 0.10 |
| Cash Ratio | 0.05 | 0.00 | 0.10 |
| Solvency Ratio | 0.83 | 0.87 | 1.16 |
| Operating Cash Flow Ratio | -0.35 | -0.10 | 0.01 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -181.19K | $ -246.66K | $ -233.13K |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.05 | -0.00 | -0.11 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.06 | 0.08 | -0.41 |
| Profitability Margins | |||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -100.30% | -902.33% | 86.13% |
| EBITDA Margin | 1578.65% | -902.67% | 86.13% |
| Operating Profit Margin | -100.30% | -902.67% | 86.13% |
| Pretax Profit Margin | -100.30% | -902.33% | 86.13% |
| Net Profit Margin | -100.30% | -902.33% | 86.13% |
| Continuous Operations Profit Margin | -100.30% | -902.33% | 86.13% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.00% | 99.96% | 99.99% |
| Return on Assets (ROA) | -101.00% | -1218.27% | 246.52% |
| Return on Equity (ROE) | 5.54% | 5.49% | -27.71% |
| Return on Capital Employed (ROCE) | 5.54% | 5.49% | -27.71% |
| Return on Invested Capital (ROIC) | 5.54% | 5.49% | -27.71% |
| Return on Tangible Assets | -101.00% | -1218.27% | 246.52% |
| Earnings Yield | -0.07% | -0.05% | 0.24% |
| Efficiency Ratios | |||
| Receivables Turnover | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 1.01 | 1.35 | 2.86 |
| Working Capital Turnover Ratio | -0.05 | -0.01 | -0.27 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | -0.00 | -0.00 | 0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -6.67 | -16.73 | 0.05 |
| Free Cash Flow Yield | -0.48% | -0.08% | 0.01% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | -1394.73 | -2207.82 | 408.19 |
| Price-to-Sales (P/S) Ratio | 1398.92 | 19921.89 | 351.56 |
| Price-to-Book (P/B) Ratio | -77.21 | -121.15 | -113.10 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -209.80 | -1190.93 | 7570.26 |
| Price-to-Operating Cash Flow Ratio | -209.80 | -1190.93 | 7570.26 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 18.59 | -1.66 |
| Enterprise Value Multiple | 88.55 | -2206.92 | 407.76 |
| Enterprise Value | 13.98M | 29.88M | 26.34M |
| EV to EBITDA | 88.55 | -2206.92 | 407.76 |
| EV to Sales | 1397.92 | 19921.15 | 351.21 |
| EV to Free Cash Flow | -209.65 | -1190.89 | 7562.73 |
| EV to Operating Cash Flow | -209.65 | -1190.89 | 7562.73 |
| Tangible Book Value Per Share | -0.00 | -0.01 | -0.01 |
| Shareholders’ Equity Per Share | -0.00 | -0.01 | -0.01 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | 0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 |
| Income Quality | 6.65 | 1.85 | 0.05 |
Currency in USD
